<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
68263-223-00
</NDCCode>
<PackageDescription>
3 mL in 1 VIAL (68263-223-00)
</PackageDescription>
<NDC11Code>
68263-0223-00
</NDC11Code>
<ProductNDC>
68263-223
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Taurolidine, Heparin
</NonProprietaryName>
<DosageFormName>
SOLUTION
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20240101
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
ROVI Pharma Industrial Services SA
</LabelerName>
<SubstanceName>
HEPARIN; TAUROLIDINE
</SubstanceName>
<StrengthNumber>
3000; 40.5
</StrengthNumber>
<StrengthUnit>
[USP'U]/3mL; mg/3mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2025-03-13
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
01-JAN-24
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>